Aaron Ren
Vorstandsvorsitzender bei Sironax Ltd.
Ursprung des Netzwerks ersten Grades von Aaron Ren
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 15 | |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Aaron Ren
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal General Counsel | |
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| WUXI APPTEC CO., LTD. | Pharmaceuticals: Major | Chief Investment Officer Director/Board Member Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
| CSTONE PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Wuxi New Life Science Investment Ltd.
 Wuxi New Life Science Investment Ltd. Financial ConglomeratesFinance Wuxi New Life Science Investment Ltd. is a Chinese company that provides investment services. The private company is based in Shanghai, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Tsinghua University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| BEIGENE, LTD. | Pharmaceuticals: Major | Founder Director/Board Member | |
General Atlantic Asia Ltd.
 General Atlantic Asia Ltd. Investment ManagersFinance General Atlantic Asia Ltd. is a Private Equity/Venture Capital firm, a subsidiary of General Atlantic LLC founded in 2007. General Atlantic Asia Ltd. is headquartered in Hong Kong. | Investment Managers | Director of Investments Private Equity Analyst | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
LifeMine Therapeutics, Inc.
 LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wuxi Biologics Holdings Ltd.
 Wuxi Biologics Holdings Ltd. Financial ConglomeratesFinance Wuxi Biologics Holdings Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WUXI BIOLOGICS (CAYMAN) INC. | Biotechnology | Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| University of Virginia | College/University | Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree | |
| BRI-Alzan, Inc. | Director/Board Member | ||
| Bri-Tolan, Inc. | Director/Board Member | ||
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Eikonizo Therapeutics, Inc.
 Eikonizo Therapeutics, Inc. Medical/Nursing ServicesHealth Services Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA. | Medical/Nursing Services | Director/Board Member | |
Digital Cognition Technologies, Inc.
 Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Medical Specialties | Director/Board Member | |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Director/Board Member | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | President | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| Aratome, LLC | Director/Board Member | ||
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
Cerapedics, Inc.
 Cerapedics, Inc. Pharmaceuticals: MajorHealth Technology Cerapedics, Inc. engaged in the provision of developing and commercializing novel osteobiologic products. It offers i-FACTOR Bone Graft, an advanced biologic that supported with level I evidence, and provides benefit ratio. The company was founded by Andrew J. Tofe and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member | |
VaxEquity Ltd.
 VaxEquity Ltd. BiotechnologyHealth Technology VaxEquity Ltd. is a UK biotechnology company founded in 2020 by Professor Robin Shattock, the head of immunology of infection at Imperial College and Morningside. The company is based in Little Chesterford, UK. The British company is developing transformative RNA therapeutics and vaccines using its next-generation self-amplifying RNA platform called SARNA. The platform provides extended duration of protein expression, enabling lower doses to be used for vaccines and higher protein levels to be achieved for therapeutics. VaxEquity is pioneering a next-generation approach by modifying its SARNA to modulate the innate immune response and thereby overcoming current limitations. The flexibility of the company's platform ensures that its broad pipeline of assets can be designed, developed, and manufactured rapidly and at scale. | Biotechnology | Director/Board Member | |
Inscopix, Inc.
 Inscopix, Inc. BiotechnologyHealth Technology Inscopix, Inc. develops and produces miniature integrated microscopes and related devices. It is categorized under the research and development in the physical, engineering, and life sciences industry. The firm specializes in neuroscience, life science research tools, in vivo brain imaging, electrophysiology, neurotechnology, miniature microscope, calcium imaging areas. The company was founded by Mark Schnitzer, Kunal Ghosh and Abbas El Gamal in 2011 and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
Enspectra Health, Inc.
 Enspectra Health, Inc. Medical SpecialtiesHealth Technology Enspectra Health, Inc. engages in the provision of visualization of cellular structures. It develops micro-endoscopy system. The company was founded by Gabriel Sanchez, Mark Schnitzer, and Scott Delp and is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca Holding GmbH
 AstraZeneca Holding GmbH Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Holding GmbH functions as an investment holding German company. The company is based in Wedel, Germany. The CEO of the company is Hans Sijbesma. | Financial Conglomerates | Chief Executive Officer | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Operating Officer | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Operating Officer | |
| École Nationale Vétérinaire d'Alfort | College/University | Doctorate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chairman |
Statistik
International
| Vereinigte Staaten | 31 |
| China | 7 |
| Vereinigtes Königreich | 5 |
| Cayman Islands | 3 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 28 |
| Finance | 9 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Health Services | 2 |
Operativ
| Director/Board Member | 149 |
| Corporate Officer/Principal | 39 |
| Independent Dir/Board Member | 25 |
| Chief Executive Officer | 20 |
| Undergraduate Degree | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Edward Hu | 29 |
| Auerbach Daniel | 27 |
| Yan Ling Cao | 21 |
| Andreas Wicki | 21 |
| Pascal Soriot | 17 |
| Tyrell J. Rivers | 17 |
| Xiao Meng Tong | 15 |
| Stacie Weninger | 15 |
| Jacques Suzanne | 15 |
| Christian Nolet | 15 |
| Xiao Dong Wang | 11 |
| Zheng Bin Yao | 11 |
| Ranjeev Krishana | 9 |
| Jörn Drappa | 9 |
| Jim Kastenmayer | 8 |